Reduction in central systolic BP from baseline to week 8 , the primary efficacy variable , was significantly greater in the N30 + V80 group ( -27.214.7 mmHg ) and the N60 group ( -27.116.5 mmHg ) compared with V160 group ( -14.416.6 mmHg ) .